Clinical Trials in Phoenix

Showing 4381-4400 of 16,646 trials

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

NCT05580588

Study SPH4336-US-01 is an open-label (no placebo), multicenter clinical trial to evaluate the safety, blood levels (pharmacokinetics) and preliminary anti-tumor effects of SPH4336, a selective enzyme blocker, in patients with specific types of liposarcomas (tumors expressing the target of the study drug).

Liposarcoma, Dedifferentiated

Shanghai Pharma Biotherapeutics USA Inc.14 participantsStarted Aug 2023

Phoenix, Arizona, United States • Duarte, California, United States • Jacksonville, Florida, United States +6 more locations

COMPLETEDPhase 2< 1 mile

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

NCT04640077

The main goals of this study are to further determine whether the study drug donanemab is safe and effective in participants with Alzheimer's disease and to validate neuropsychological assessments administered over videoconferencing

Alzheimer DiseaseDementiaBrain Diseases+2 more

Eli Lilly and Company95 participantsStarted Nov 2020

Phoenix, Arizona, United States • Irvine, California, United States • Bradenton, Florida, United States +24 more locations

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Find Trials by Condition in Phoenix

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Reproductive Health Program in Patients With Cancer

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Pioglitazone for the Treatment of Alcohol Use Disorder

ColoCare Study - Colorectal Cancer Cohort

Multi-Center Study of ManNAc for GNE Myopathy

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Shared-Decision Making for Hydroxyurea

DETECT-RPC Universal EM Screening